{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T01:51:51Z","timestamp":1778723511761,"version":"3.51.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Clinique et Biologique"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.tracli.2024.06.007","type":"journal-article","created":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T16:49:17Z","timestamp":1718988557000},"page":"195-200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Anti-A and anti-B titers in A, B and O whole blood donors: Beyond \u201cdangerous O\u201d"],"prefix":"10.1016","volume":"31","author":[{"given":"Amit Kumar","family":"Chatterjee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pandeep","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davood","family":"Bava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akarshan","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tracli.2024.06.007_b0005","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.resuscitation.2004.09.001","article-title":"Karl Landsteiner, the discoverer of blood groups","volume":"63","author":"Figl","year":"2004","journal-title":"Resuscitation"},{"key":"10.1016\/j.tracli.2024.06.007_b0010","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1084\/jem.13.4.425","article-title":"Studies in isoagglutination: I. Transfusion and the question of intravascular agglutination","volume":"13","author":"Ottenberg","year":"1911","journal-title":"J Exp Med"},{"key":"10.1016\/j.tracli.2024.06.007_b0015","series-title":"T\u00e9cnicas Modernas em Banco de Sangue e Transfus\u00e3o","first-page":"90","year":"2006"},{"key":"10.1016\/j.tracli.2024.06.007_b0020","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4103\/GJTM.GJTM_38_20","article-title":"Prevalence of high titered anti-A and anti-B antibodies among O blood group individuals and their associated factors","volume":"5","author":"Kannan","year":"2020","journal-title":"Global J Transfusion Med"},{"key":"10.1016\/j.tracli.2024.06.007_b0025","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4103\/ajts.AJTS_36_17","article-title":"Incompatible crossmatch: first sign of a hemolytic transfusion reaction due to out-of-group platelet transfusion","volume":"13","author":"Basu","year":"2019","journal-title":"Asian J Transfusion Sci"},{"key":"10.1016\/j.tracli.2024.06.007_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2023.103658","article-title":"Acute hemolytic transfusion reaction following ABO-mismatched platelet transfusion: two case reports","volume":"62","author":"Zulkeflee","year":"2023","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.tracli.2024.06.007_b0035","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4103\/0973-6247.200765","article-title":"Antibody titers in Group O platelet donors","volume":"11","author":"Tendulkar","year":"2017","journal-title":"Asian J Transfus Sci"},{"key":"10.1016\/j.tracli.2024.06.007_b0040","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.htct.2020.03.008","article-title":"Comparison of abo antibody levels in apheresis platelets suspended in platelet additive solution and plasma","volume":"7","author":"Kc","year":"2021","journal-title":"Hematol Transfusion Cell Ther"},{"key":"10.1016\/j.tracli.2024.06.007_b0045","article-title":"Use of platelet components: An observational audit at a tertiary care centre","volume":"34","author":"Chenna","year":"2021","journal-title":"Natl Med J India"},{"key":"10.1016\/j.tracli.2024.06.007_b0050","doi-asserted-by":"crossref","first-page":"425","DOI":"10.4049\/jimmunol.8.6.425","article-title":"A dangerous \u201cuniversal donor\u201d detected by the direct matching of bloods","volume":"8","author":"Levine","year":"1923","journal-title":"J Immunol"},{"key":"10.1016\/j.tracli.2024.06.007_b0055","first-page":"1","article-title":"How to calculate sample size for observational and experimental nursing research studies","volume":"10","author":"Sharma","year":"2020","journal-title":"Natl J Physiol Pharm Pharmacol"},{"key":"10.1016\/j.tracli.2024.06.007_b0060","unstructured":"Ministry of Health and Family Welfare. Drugs and Cosmetics (Second Amendment) Rules, 2020. GSR 166(E). New Delhi (India); 2020 March. Pp. 15. Available from: https:\/\/thehealthmaster.com\/wp-content\/uploads\/2020\/03\/GSR-166-E-11-03-20-Blood-Bank-Blood-Centre.pdf."},{"key":"10.1016\/j.tracli.2024.06.007_b0065","unstructured":"AABB Technical Manual, 20th Edition: Methods and Appendices. https:\/\/www.aabb.org\/docs\/default-source\/default-document-library\/publications\/technical-manual-20th-edition-methods-and-appendices.docx?sfvrsn=8c9876fe_2. Accessed September 8, 2021."},{"key":"10.1016\/j.tracli.2024.06.007_b0070","doi-asserted-by":"crossref","first-page":"114S","DOI":"10.1111\/trf.12045","article-title":"Risks of hemolysis due to anti-A and anti-B caused by the transfusion of blood or blood components containing ABO-incompatible plasma","volume":"53","author":"Bers\u00e9us","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2024.06.007_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-020-02378-w","article-title":"Complement activating ABO anti-A IgM\/IgG act synergistically to cause erythrophagocytosis: implications among minor ABO incompatible transfusions","volume":"18","author":"Pandey","year":"2020","journal-title":"J Transl Med"},{"key":"10.1016\/j.tracli.2024.06.007_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2021.103341","article-title":"High titers of anti-A1 and anti-B antibodies among Peruvian group O platelet donors","volume":"61","author":"Aguilar","year":"2022","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.tracli.2024.06.007_b0085","first-page":"104","article-title":"Antibody titers study in group O blood donors: tube and column agglutination techniques","volume":"2","author":"Sood","year":"2016","journal-title":"J Thrombo Cir"},{"key":"10.1016\/j.tracli.2024.06.007_b0090","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4103\/ijh.ijh_43_20","article-title":"Evaluation of anti-A and anti-B IgM and anti-AB IgG antibody titers in Group O blood Iraqi donors","volume":"9","author":"Jassim","year":"2020","journal-title":"Iraqi Journal of Hematology"},{"key":"10.1016\/j.tracli.2024.06.007_b0095","doi-asserted-by":"crossref","first-page":"259","DOI":"10.5581\/1516-8484.20110073","article-title":"Titers of ABO antibodies in group O blood donors","volume":"33","author":"de Fran\u00e7a","year":"2011","journal-title":"Rev Bras Hematol Hemoter"},{"key":"10.1016\/j.tracli.2024.06.007_b0100","first-page":"24","article-title":"Evaluation of anti-A and anti-B Alloisogglutinin titer in group O plateletpheresis donors","volume":"5","author":"Chaudhari","year":"2017","journal-title":"Int J Res Med"},{"key":"10.1016\/j.tracli.2024.06.007_b0105","first-page":"76","article-title":"Evaluation of anti-A and anti-B alloisogglutinin titer in group O plateletpheresis donors","volume":"1","author":"Bazigou","year":"2015","journal-title":"Hematol Transfus Int J"},{"key":"10.1016\/j.tracli.2024.06.007_b0110","doi-asserted-by":"crossref","DOI":"10.3329\/bjms.v21i2.58070","article-title":"Determination of ABO antibody titre and haemolysin test of group O whole blood used for exchanged transfusion in a teaching hospital","volume":"21","author":"Mohd Noor","year":"2022","journal-title":"Bangladesh J Med Sci"},{"key":"10.1016\/j.tracli.2024.06.007_b0115","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1111\/trf.13114","article-title":"Anti-A and anti-B titers in donor plasma, plasma pools, and immunoglobulin final products","volume":"55","author":"McVey","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2024.06.007_b0120","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1590\/S1516-84842004000100006","article-title":"Freq\u00fc\u00eancia de hemolisinas anti-A e anti-B em doadores de sangue do Hemocentro de Botucatu","volume":"26","author":"Gambero","year":"2004","journal-title":"Rev Bras Hematol Hemoter"},{"key":"10.1016\/j.tracli.2024.06.007_b0125","doi-asserted-by":"crossref","DOI":"10.18502\/ijml.v6i4.1998","article-title":"Prevalence and haemolytic significance of red cell antibodies among dangerous universal donors in a Tertiary Care Hospital in South India","author":"Amita","year":"2019","journal-title":"Int J Medical Lab"},{"key":"10.1016\/j.tracli.2024.06.007_b0130","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0140-6736(54)92397-1","article-title":"Potentially dangerous group-O blood: a screening test","volume":"263","author":"Gardner","year":"1954","journal-title":"Lancet"},{"key":"10.1016\/j.tracli.2024.06.007_b0135","first-page":"253","article-title":"High frequency of IgG anti-A and-B antibody in old age","volume":"30","author":"Baumgarten","year":"1976","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2024.06.007_b0140","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1182\/blood.V5.6.553.553","article-title":"Dangerous Universal Donors: II. Further observations on in vivo and in vitro behavior of isoantibodies of immune type present in group O Blood","volume":"5","author":"Ervin","year":"1950","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2024.06.007_b0145","first-page":"307","article-title":"Characteristics of anti-A and anti-B in black Zimbabweans","volume":"67","author":"Adewuyi","year":"1994","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2024.06.007_b0150","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/jcla.21499","article-title":"The characteristics of ABO antibodies in group OT hai blood donors","volume":"26","author":"Khampanon","year":"2012","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.tracli.2024.06.007_b0155","article-title":"Anti-A and anti-B haemolysins amongst group \u201cO\u201d voluntary blood donors in northeastern Nigeria","volume":"2011","author":"Kagu","year":"2011","journal-title":"J Blood Transfusion"},{"key":"10.1016\/j.tracli.2024.06.007_b0160","first-page":"45","article-title":"Adolescents and blood donation: motivations, hurdles and possible recruitment strategies","volume":"10","author":"Zito","year":"2012","journal-title":"Blood Transfus"},{"key":"10.1016\/j.tracli.2024.06.007_b0165","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.3181\/00379727-141-36943","article-title":"Blood group antibodies in old age","volume":"141","author":"Somers","year":"1972","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.tracli.2024.06.007_b0170","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF03324152","article-title":"The effect of age on the level of human ABO blood group antibodies","volume":"5","author":"Saphire","year":"1993","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.tracli.2024.06.007_b0175","doi-asserted-by":"crossref","unstructured":"Fischinger S, Boudreau CM, Butler AL, Streeck H, Alter G. Sex differences in vaccine-induced humoral immunity. In: Seminars in immunopathology 2019 Mar 15 (Vol. 41, pp. 239-249). Springer Berlin Heidelberg.","DOI":"10.1007\/s00281-018-0726-5"},{"key":"10.1016\/j.tracli.2024.06.007_b0180","article-title":"Current perspective of plant-based diets on communicable diseases caused by viruses: a mini review","volume":"16","author":"Wong","year":"2022","journal-title":"Front Nutr"},{"key":"10.1016\/j.tracli.2024.06.007_b0185","series-title":"Blood groups and red cell antigens","author":"Dean","year":"2005"},{"key":"10.1016\/j.tracli.2024.06.007_b0190","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1111\/j.1537-2995.2012.03574.x","article-title":"ABO antibody titers are not predictive of hemolytic reactions due to plasma-incompatible platelet transfusions","volume":"52","author":"Karafin","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2024.06.007_b0195","doi-asserted-by":"crossref","first-page":"5","DOI":"10.21307\/immunohematology-2021-002","article-title":"Group O blood donors in Iran: evaluation of isoagglutinin titers and immunoglobulin G subclasses","volume":"37","author":"Arabi","year":"2021","journal-title":"Immunohematology"},{"key":"10.1016\/j.tracli.2024.06.007_b0200","doi-asserted-by":"crossref","first-page":"25","DOI":"10.21307\/immunohematology-2021-006","article-title":"Comparative evaluation of the conventional tube test and column agglutination technology for ABO antibody titration in healthy individuals: a report from India","volume":"37","author":"Datta","year":"2021","journal-title":"Immunohematology"},{"key":"10.1016\/j.tracli.2024.06.007_b0205","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4103\/0973-6247.214343","article-title":"Comparison of antibody titers using conventional tube technique versus column agglutination technique in ABO blood group incompatible renal transplant","volume":"11","author":"Bhangale","year":"2017","journal-title":"Asian Journal of Transfusion Science"},{"key":"10.1016\/j.tracli.2024.06.007_b0210","first-page":"147","article-title":"Comparative study of ABO antibody titers using conventional tube technique and automated column agglutination technique","volume":"30","author":"Onpuns","year":"2020","journal-title":"J Hematol Transfusion Med"}],"container-title":["Transfusion Clinique et Biologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782024000685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782024000685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T16:16:16Z","timestamp":1730391376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1246782024000685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1246782024000685"],"URL":"https:\/\/doi.org\/10.1016\/j.tracli.2024.06.007","relation":{},"ISSN":["1246-7820"],"issn-type":[{"value":"1246-7820","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-A and anti-B titers in A, B and O whole blood donors: Beyond \u201cdangerous O\u201d","name":"articletitle","label":"Article Title"},{"value":"Transfusion Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tracli.2024.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Soci\u00e9t\u00e9 fran\u00e7aise de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}